Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 December 1995:
Vol. 270. no. 5243, pp. 1842 - 1845
DOI: 10.1126/science.270.5243.1842
Prev | Table of Contents | Next

Reports

Solution Structure of a Cisplatin-Induced DNA Interstrand Cross-Link

Huifang Huang (1),  Leiming Zhu (1),  Brian R. Reid,  Gary P. Drobny (2),  Paul B. Hopkins (2)

The widely used antitumor drug cis-diamminedichloroplatinum(II) (cisplatin or cis-DDP) reacts with DNA, cross-linking two purine residues through the N7 atoms, which reside in the major groove in B-form DNA. The solution structure of the short duplex [d(CATAGCTATG)]2 cross-linked at the GC:GC site was determined by nuclear magnetic resonance (NMR). The deoxyguanosine-bridging cis-diammineplatinum(II) lies in the minor groove, and the complementary deoxycytidines are extrahelical. The double helix is locally reversed to a left-handed form, and the helix is unwound and bent toward the minor groove. These findings were independently confirmed by results from a phase-sensitive gel electrophoresis bending assay. The NMR structure differs markedly from previously proposed models but accounts for the chemical reactivity, the unwinding, and the bending of cis-DDP interstrand cross-linked DNA and may be important in the formation and repair of these cross-links in chromatin.


H. Huang, L. Zhu, G. P. Drobny, P. B. Hopkins, Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
B. R. Reid, Departments of Chemistry and Biochemistry, University of Washington, Seattle, WA 98195, USA.
(1) These authors contributed equally to this work.
(2) To whom correspondence should be addressed.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.
R. N. Bose, L. Maurmann, R. J. Mishur, L. Yasui, S. Gupta, W. S. Grayburn, H. Hofstetter, and T. Salley (2008)
PNAS 105, 18314-18319
   Abstract »    Full Text »    PDF »
Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
K. Chvalova, V. Brabec, and J. Kasparkova (2007)
Nucleic Acids Res. 35, 1812-1821
   Abstract »    Full Text »    PDF »
Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands.
S. Zorbas-Seifried, M. A. Jakupec, N. V. Kukushkin, M. Groessl, C. G. Hartinger, O. Semenova, H. Zorbas, V. Yu. Kukushkin, and B. K. Keppler (2007)
Mol. Pharmacol. 71, 357-365
   Abstract »    Full Text »    PDF »
Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of Antitumor trans-[PtCl2(NH3)(thiazole)].
V. Marini, P. Christofis, O. Novakova, J. Kasparkova, N. Farrell, and V. Brabec (2005)
Nucleic Acids Res. 33, 5819-5828
   Abstract »    Full Text »    PDF »
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis.
D. Villa, M. Miloso, G. Nicolini, R. Rigolio, A. Villa, G. Cavaletti, and G. Tredici (2005)
Mol. Cancer Ther. 4, 1439-1447
   Abstract »    Full Text »    PDF »
Solution structure of a nitrous acid induced DNA interstrand cross-link.
N. B. F. Edfeldt, E. A. Harwood, S. Th. Sigurdsson, P. B. Hopkins, and B. R. Reid (2004)
Nucleic Acids Res. 32, 2785-2794
   Abstract »    Full Text »    PDF »
Sequence context effect on the structure of nitrous acid induced DNA interstrand cross-links.
N. B. F. Edfeldt, E. A. Harwood, S. Th. Sigurdsson, P. B. Hopkins, and B. R. Reid (2004)
Nucleic Acids Res. 32, 2795-2801
   Abstract »    Full Text »    PDF »
Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand: MECHANISTIC STUDIES ON ANTITUMOR ACTION.
J. Kasparkova, O. Novakova, V. Marini, Y. Najajreh, D. Gibson, J.-M. Perez, and V. Brabec (2003)
J. Biol. Chem. 278, 47516-47525
   Abstract »    Full Text »    PDF »
DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes.
O. Novakova, J. Kasparkova, J. Malina, G. Natile, and V. Brabec (2003)
Nucleic Acids Res. 31, 6450-6460
   Abstract »    Full Text »    PDF »
Unusual DNA duplex and hairpin motifs.
S.-H. Chou, K.-H. Chin, and A. H.-J. Wang (2003)
Nucleic Acids Res. 31, 2461-2474
   Abstract »    Full Text »    PDF »
DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464. CONFORMATION, RECOGNITION BY HIGH MOBILITY GROUP DOMAIN PROTEINS, AND NUCLEOTIDE EXCISION REPAIR.
J. Kasparkova, J. Zehnulova, N. Farrell, and V. Brabec (2002)
J. Biol. Chem. 277, 48076-48086
   Abstract »    Full Text »    PDF »
DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent.
K. Stehlikova, H. Kostrhunova, J. Kasparkova, and V. Brabec (2002)
Nucleic Acids Res. 30, 2894-2898
   Abstract »    Full Text »    PDF »
Flow cytometric detection of apoptotic bone marrow cells with fractional DNA content after application of WR-2721, cyclophosphamide, cisplatin, and exposure of mice to gamma rays.
L Mazur, A Czyzewska, and M Bochenek (2002)
Human and Experimental Toxicology 21, 335-341
   Abstract »    PDF »
Phosphate backbone neutralization increases duplex DNA flexibility: A model for protein binding.
T. M. Okonogi, S. C. Alley, E. A. Harwood, P. B. Hopkins, and B. H. Robinson (2002)
PNAS 99, 4156-4160
   Abstract »    Full Text »    PDF »
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways.
M. S. Park, M. De Leon, and P. Devarajan (2002)
J. Am. Soc. Nephrol. 13, 858-865
   Abstract »    Full Text »    PDF »
Nucleic acid duplexes incorporating a dissociable covalent base pair.
K. Gao and L. E. Orgel (1999)
PNAS 96, 14837-14842
   Abstract »    Full Text »    PDF »
DNA Interactions of New Antitumor Aminophosphine Platinum(II) Complexes.
K. Neplechová, O. Nováková, A. Habtemariam, B. Watchman, P. J. Sadler, and V. Brabec (1999)
Mol. Pharmacol. 56, 20-30
   Abstract »    Full Text »
Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin.
J. Zlatanova, J. Yaneva, and S. H. Leuba (1998)
FASEB J 12, 791-799
   Abstract »    Full Text »
Human Ku Autoantigen Binds Cisplatin-damaged DNA but Fails to Stimulate Human DNA-activated Protein Kinase.
J. J. Turchi and K. Henkels (1996)
J. Biol. Chem. 271, 13861-13867
   Abstract »    Full Text »    PDF »
Sequence Specificity, Conformation, and Recognition by HMG1 Protein of Major DNA Interstrand Cross-links of Antitumor Dinuclear Platinum Complexes.
J. Kasparkova, N. Farrell, and V. Brabec (2000)
J. Biol. Chem. 275, 15789-15798
   Abstract »    Full Text »    PDF »
Thermal and Thermodynamic Properties of Duplex DNA Containing Site-specific Interstrand Cross-link of Antitumor Cisplatin or Its Clinically Ineffective Trans Isomer.
C. Hofr and V. Brabec (2001)
J. Biol. Chem. 276, 9655-9661
   Abstract »    Full Text »    PDF »
Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464.
J. Zehnulova, J. Kasparkova, N. Farrell, and V. Brabec (2001)
J. Biol. Chem. 276, 22191-22199
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)